https://doi.org/10.4081/itjm.2025.1874
Effect of magnesium and potassium on rheumatoid arthritis factor and quality of life in patients with type 2 diabetes mellitus: a randomized control trial
Submitted: 6 December 2024
Accepted: 23 February 2025
Published: 18 March 2025
Accepted: 23 February 2025
Abstract Views: 77
PDF: 32
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The management of type 2 diabetes mellitus (T2DM) and its related consequences, such as the prevalence of rheumatoid arthritis (RA) factor and overall quality of life, has drawn increased attention to the significance of micronutrients, particularly magnesium (Mg+2) and potassium (K+). The objective of this study is to investigate the effects of Mg+2 and/or K+ supplementation on the RA factor and quality of life in T2DM patients. This randomized controlled trial (single-blinded) was conducted at Lahore Garrison University and Lahore Medical Research Center. The sample size consisted of 80 diabetic patients. Four groups were formed based on the supplementation they received. Samples were taken before the use of Mg and K supplements and after 60 days of supplements taken. Quality of life assessments, including physical functioning, mental health, social functioning, and overall well-being, were measured in our study. Data were analyzed statistically by using GraphPad Prism 8.0.2. The study results show that group 2, which received Mg+2 supplements, had the highest mean pre-treatment RA factor value and showed a decrease in RA factor after the treatment. Our result showed that supplements of Mg+2 have an effective role in lowering the level of RA factor. In light of these results, future prospects for research could focus on investigating the mechanisms by which Mg+2 and K+ supplements impact glycated hemoglobin levels and RA factor to optimize treatment strategies for individuals with diabetes and RA.
Brandão-Lima PN, de Carvalho GB , Fonseca Santos RK, et al. Intakes of zinc, potassium, calcium, and magnesium of individuals with type 2 diabetes mellitus and the relationship with glycemic control. Nutrients 2018;10:1948.
DOI: https://doi.org/10.3390/nu10121948
Timmis A, Vardas P, Townsend N, et al. European Society of Cardiology: cardiovascular disease statistics 2021. EurHeart J 2022;43:716-99. Erratum in: Eur Heart J 2022;43:799.
DOI: https://doi.org/10.1093/eurheartj/ehac064
Anwar A, Khan HA, Hafeez S, Firdous K. A comparative study of creatine kinase-MB and Troponin levels among diabetic and non-diabetic patients with acute MI. Pak J Med Health Sci 2016;10:296-7.
Evliyaoğlu O, Kibrisli E, Yildirim Y, et al. Routine enzymes in the monitoring of type 2 diabetes mellitus. Cell Biochem Funct 2011;29:506-12.
DOI: https://doi.org/10.1002/cbf.1779
Esser N, Paquot N, Scheen AJ. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Expert Opin Investig Drugs 2015;24:283-307.
DOI: https://doi.org/10.1517/13543784.2015.974804
Pistrosch F, Ganz X, Bornstein SR, et al. Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions. Acta Diabetol 2015;52:889-95.
DOI: https://doi.org/10.1007/s00592-015-0727-y
Liu XZ, Gao Y, Fan J, et al. Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus. Clin Rheumatol 2018;37:219-26.
DOI: https://doi.org/10.1007/s10067-017-3847-7
Uhlig T, Moe RH, Kvien TK. The burden of disease in rheumatoid arthritis. Pharmacoeconomics 2014;32:841-51.
DOI: https://doi.org/10.1007/s40273-014-0174-6
Kianifard T, Saluja M, Sarmukaddam S, et al. An adjunct role of potassium rich vegetarian diet and a novel potassium food supplement to improve pain in chronic rheumatoid arthritis on supervised standard care: a randomized controlled study. BMJ Nutr Prev Health 2024;7:14-25.
DOI: https://doi.org/10.1136/bmjnph-2023-000674
Fohse FK, Rollefstad S, Ikdahl E, et al. Degree of arterial stiffness is comparable across inflammatory joint disease entities. Scand J Rheumatol 2022;51:186-95.
DOI: https://doi.org/10.1080/03009742.2021.1920169
Ramos AL, Redeker I, Hoffmann F, et al. Comorbidities in patients with rheumatoid arthritis and their association with patient reported outcomes: results of claims data linked to questionnaire survey. J Rheumatol 2019;46:564-71.
DOI: https://doi.org/10.3899/jrheum.180668
Hu H, Luan L, Yang K, Li SC. Burden of rheumatoid arthritis from a societal perspective: a prevalence‐based study on cost of this illness for patients in China. Int J Rheum Dis 2018; 21:1572-80.
DOI: https://doi.org/10.1111/1756-185X.13028
Radner H, Yoshida K, Hmamouchi I, et al. Treatment patterns of multimorbid patients with rheumatoid arthritis: results from an international cross-sectional study. J Rheumatol 2015;42:1099-104.
DOI: https://doi.org/10.3899/jrheum.141534
Cannata F, Vadalà G, Russo F, et al. Beneficial effects of physical activity in diabetic patients. J Funct Morphol Kinesiol 2020;5:70.
DOI: https://doi.org/10.3390/jfmk5030070
Kianifard T, Chopra A. A therapeutic role for potassium (K) to reduce pain and complications related to the cardiovascular system and bone in rheumatoid arthritis (RA): a clinical research perspective. Rheumatol Res 2018;3:1-12.
DOI: https://doi.org/10.22631/rr.2017.69997.1035
Abhishek A, Doherty M, Kuo CF, et al. Rheumatoid arthritis is getting less frequent - results of a nationwide population-based cohort study. Rheumatology 2017;56:736-44.
DOI: https://doi.org/10.1093/rheumatology/kew468
Nagy G, Roodenrijs NM, Welsing PM, et al. EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 2021;80:31-5.
DOI: https://doi.org/10.1136/annrheumdis-2020-217344
Ursini F, Russo E, D’Angelo S, et al. Prevalence of undiagnosed diabetes in rheumatoid arthritis: an OGTT study. Medicine 2016;95:e2552.
DOI: https://doi.org/10.1097/MD.0000000000002552
Barbagallo M, Veronese N, Dominguez LJ. Magnesium in aging, health and diseases. Nutrients 2021;13:463.
DOI: https://doi.org/10.3390/nu13020463
Dibaba DT, Xun P, He K. Dietary magnesium intake is inversely associated with serum C- reactive protein levels: meta-analysis and systematic review. Eur J Clin Nutr 2014;68:510-6.
DOI: https://doi.org/10.1038/ejcn.2014.7
Asbaghi O, Hosseini R, Boozari B, et al. The effects of magnesium supplementation on blood pressure and obesity measure among type 2 diabetes patient: a systematic review and meta-analysis of randomized controlled trials. Biol Trace Elem Res 2021;199:413-24.
DOI: https://doi.org/10.1007/s12011-020-02157-0
Zhou H, Liang B, Jiang H, et al. Magnesium-based biomaterials as emerging agents for bone repair and regeneration: from mechanism to application. J Magnes Alloy 2021;9:779-804.
DOI: https://doi.org/10.1016/j.jma.2021.03.004
Zoroddu MA, Aaseth J, Crisponi G, et al. The essential metals for humans: a brief overview. J Inorg Biochem 2019;195:120-9.
DOI: https://doi.org/10.1016/j.jinorgbio.2019.03.013
Palaka E, Grandy S, Darlington O, et al. Associations between serum potassium and adverse clinical outcomes: a systematic literature review. Int J Clin Pract 2020;74:e13421.
DOI: https://doi.org/10.1111/ijcp.13421
Kaya A, Keskin M, Tatlisu MA, Kayapinar O. Effect of dynamic potassium change on in- hospital mortality, ventricular arrhythmias, and long-term mortality in STEMI. Angiology 2019;70:69-77.
DOI: https://doi.org/10.1177/0003319718784127
Tveden-Nyborg P, Bergmann TK, Jessen N, et al. BCPT 2023 policy for experimental and clinical studies. Basic Clin Pharmacol Toxicol 2023;133:391-6.
DOI: https://doi.org/10.1111/bcpt.13944
Syrjänen S, Lappalainen R, Markkanen H. Salivary and serum levels of electrolytes and immunomarkers in edentulous healthy subjects and in those with rheumatoid arthritis. Clin Rheumatol 1986;5:49-55.
DOI: https://doi.org/10.1007/BF02030967
Rastmanesh R, Abargouei AS, Shadman Z, et al. A pilot study of potassium supplementation in the treatment of hypokalemic patients with rheumatoid arthritis: a randomized, double-blinded, placebo-controlled trial. J Pain 2008;9:722-31.
DOI: https://doi.org/10.1016/j.jpain.2008.03.006
Li J, Li Y, Wang C, et al. Dietary potassium and magnesium intake with risk of type 2 diabetes mellitus among rural china: the henan rural cohort study. Biol Trace Elem Res 2024;202:3932-44.
DOI: https://doi.org/10.1007/s12011-023-03993-6
Chatterjee R, Colangelo LA, Yeh HC, et al. Potassium intake and risk of incident type 2 diabetes mellitus: the coronary artery risk development in young adults (CARDIA) study. Diabetologia 2012;55:1295-303.
DOI: https://doi.org/10.1007/s00125-012-2487-3
How to Cite
Bibi, H. S., Rafi, U., Khalid, S., Mehboob, R., Bibi, A., Shalabi, H. S., Zaher, M. A., & A. Abusikkien, S. (2025). Effect of magnesium and potassium on rheumatoid arthritis factor and quality of life in patients with type 2 diabetes mellitus: a randomized control trial. Italian Journal of Medicine, 19(1). https://doi.org/10.4081/itjm.2025.1874
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.